(Q37188620)
Statements
1 reference
TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity (English)
1 reference
Barney S Graham
1 reference
Teresa R Johnson
1 reference
Srinivas Rao
1 reference
Robert A Seder
1 reference
Man Chen
1 reference
3 April 2009
1 reference
1 reference
3045-3052
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference